Clinical Trial Update: Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating mometasone nasal gel for persistent allergic rhinitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• mometasone nasal gel (mometasone)

Snippet

Sponsor: EMS | Conditions: Allergic Rhinitis | Phase 3 | Status: WITHDRAWN